Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koenig

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Pediatric Cardiology|November 24, 2022
Pediatric Cardiology Fellowship Standards for Training in Exercise Medicine and Curriculum OutlineJ H Huang, S G Wittekind, A R Opotowsky, et al.
Lancet Regional Health. Americas|September 4, 2024
Continuity of care during severe civil unrest with a model of community-based HIV care: a retrospective cohort study from HaitiPatrice Joseph, Rochelle Sun, Colette Guiteau, et al.
Open Forum Infectious Diseases|July 18, 2024
Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification Among Patients With Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-income CountriesKathryn Dupnik, Vanessa R Rivera, Nancy Dorvil, et al.
Open Forum Infectious Diseases|July 9, 2025
Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 SitesCissy Kityo, Caitlyn McCarthy, Serena P Koenig, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
A bioinformatics screen reveals Hox and chromatin remodeling factors at the <i>Drosophila</i> histone locusLauren J Hodkinson, Connor Smith, H Skye Comstra, et al.
BMC Genomic Data|September 22, 2023
A bioinformatics screen reveals hox and chromatin remodeling factors at the Drosophila histone locusLauren J Hodkinson, Connor Smith, H Skye Comstra, et al.
Plos Medicine|June 9, 2023
Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from HaitiNancy Dorvil, Vanessa R Rivera, Cynthia Riviere, et al.
The Lancet. HIV|November 28, 2025
Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort studyJean Bernard Marc, Caitlyn McCarthy, Carole L Wallis, et al.
The Lancet. HIV|August 29, 2025
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trialPatrice Severe, Samuel Pierre, Fabienne Homeus, et al.
Lancet (London, England)|September 15, 2018
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis, Nafees Ahmad, Shama D Ahuja, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Pediatric Cardiology|November 24, 2022
Pediatric Cardiology Fellowship Standards for Training in Exercise Medicine and Curriculum OutlineJ H Huang, S G Wittekind, A R Opotowsky, et al.
Lancet Regional Health. Americas|September 4, 2024
Continuity of care during severe civil unrest with a model of community-based HIV care: a retrospective cohort study from HaitiPatrice Joseph, Rochelle Sun, Colette Guiteau, et al.
Open Forum Infectious Diseases|July 18, 2024
Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification Among Patients With Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-income CountriesKathryn Dupnik, Vanessa R Rivera, Nancy Dorvil, et al.
Open Forum Infectious Diseases|July 9, 2025
Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 SitesCissy Kityo, Caitlyn McCarthy, Serena P Koenig, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
A bioinformatics screen reveals Hox and chromatin remodeling factors at the <i>Drosophila</i> histone locusLauren J Hodkinson, Connor Smith, H Skye Comstra, et al.
BMC Genomic Data|September 22, 2023
A bioinformatics screen reveals hox and chromatin remodeling factors at the Drosophila histone locusLauren J Hodkinson, Connor Smith, H Skye Comstra, et al.
Plos Medicine|June 9, 2023
Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from HaitiNancy Dorvil, Vanessa R Rivera, Cynthia Riviere, et al.
The Lancet. HIV|November 28, 2025
Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort studyJean Bernard Marc, Caitlyn McCarthy, Carole L Wallis, et al.
The Lancet. HIV|August 29, 2025
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trialPatrice Severe, Samuel Pierre, Fabienne Homeus, et al.
Lancet (London, England)|September 15, 2018
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis, Nafees Ahmad, Shama D Ahuja, et al.
Pageof 10